Cargando…

Inhibition of PARP Potentiates Immune Checkpoint Therapy through miR-513/PD-L1 Pathway in Hepatocellular Carcinoma

BACKGROUND: The DNA repair enzyme poly(ADP-ribose) polymerase (PARP) is involved in DNA damage repair and cell death. However, the association between PARP's biological activities and the immune microenvironment in hepatocellular carcinoma (HCC) is unclear. The present study will explore whethe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Guoqiang, Miao, Ganggang, Li, Zhitao, Zheng, Wubin, Zhou, Chunguang, Sun, Guangshun, Cao, Hongyong, Li, Zhouxiao, Tang, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020948/ https://www.ncbi.nlm.nih.gov/pubmed/35466317 http://dx.doi.org/10.1155/2022/6988923

Ejemplares similares

Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway
por: Guangshun, Sun, et al.
Publicado: (2022)

The Effect of Anlotinib Combined with anti-PD-1 in the Treatment of Gastric Cancer
por: Zheng, Wubin, et al.
Publicado: (2022)

Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges
por: Sun, Guangshun, et al.
Publicado: (2021)

Comprehensive Analysis of VCAN Expression Profiles and Prognostic Values in HCC
por: Sun, Guangshun, et al.
Publicado: (2022)

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
por: Sun, Guoqiang, et al.
Publicado: (2021)

circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD‐L1 through NF‐κB pathway
por: Wu, Fan, et al.
Publicado: (2021)

Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
por: Li, Zhitao, et al.
Publicado: (2021)

Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer
por: Zheng, Wubin, et al.
Publicado: (2021)

Treatment of patients with cancer using PD-1/PD-L1 antibodies: Adverse effects and management strategies (Review)
por: Sun, Guangshun, et al.
Publicado: (2022)

Functional divergence of the rapidly evolving miR-513 subfamily in primates
por: Sun, Zhenghua, et al.
Publicado: (2013)

Upregulation of ADAR Promotes Breast Cancer Progression and Serves as a Potential Therapeutic Target
por: Li, Xiao, et al.
Publicado: (2021)

WNT5a in Colorectal Cancer: Research Progress and Challenges
por: Sun, Guangshun, et al.
Publicado: (2021)

Application of Animal Models in Cancer Research: Recent Progress and Future Prospects
por: Li, Zhitao, et al.
Publicado: (2021)

Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma
por: Kong, Xiangyi, et al.
Publicado: (2022)

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway
por: Rong, Dawei, et al.
Publicado: (2023)

An emerging function of circRNA-miRNAs-mRNA axis in human diseases
por: Rong, Dawei, et al.
Publicado: (2017)

MiR-513b-5p represses autophagy during the malignant progression of hepatocellular carcinoma by targeting PIK3R3
por: Jin, Wei, et al.
Publicado: (2021)

Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy
por: Li, Xiao, et al.
Publicado: (2022)

Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer
por: Li, Zhouxiao, et al.
Publicado: (2019)

Works at building 513
Publicado: (2003)

Works at building 513
Publicado: (2003)

Works at building 513
Publicado: (2003)

B513 roof
por: Grossir, Anthony
Publicado: (2011)

Work at Building 513
por: IT Department
Publicado: (2006)

Work at Building 513
por: IT Department
Publicado: (2006)

Computers in Bld. 513
Publicado: (1978)

Computers in Bld 513
Publicado: (1978)

Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy
por: Sun, Guangshun, et al.
Publicado: (2022)

Circ-SFMBT2 promotes the proliferation of gastric cancer cells through sponging miR-182-5p to enhance CREB1 expression
por: Sun, Handong, et al.
Publicado: (2018)

miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease
por: Dai, Nan, et al.
Publicado: (2016)

Fluidic Data exhibition in 513
por: Ordan, Julien Marius
Publicado: (2019)

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
por: Hao, Xiaopei, et al.
Publicado: (2022)

Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p
por: Li, Shan, et al.
Publicado: (2021)

miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation
por: Dong, Peixin, et al.
Publicado: (2018)

miR-513c-5p Suppression Aggravates Pyroptosis of Endothelial Cell in Deep Venous Thrombosis by Promoting Caspase-1
por: Chu, Chu, et al.
Publicado: (2022)

miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1
por: Zhang, Li-Juan, et al.
Publicado: (2021)

The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer
por: Delgir, Soheila, et al.
Publicado: (2021)

PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
por: Li, Qian, et al.
Publicado: (2022)

At the Central Computer Room in Bld. 513
Publicado: (1979)

At the Central Computer Room in Bld. 513
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_8031dcgno2mshc1fqjvbh198u2